Meihua International Regains Nasdaq Compliance, Meets Minimum Bid Price Requirement
Meihua International Regains Nasdaq Compliance, Meets Minimum Bid Price Requirement
Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ:MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced that on October 3, 2024, it received a notification letter (the "Notification Letter") from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), informing the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5450(a)(1) (the "Minimum Bid Price Requirement").
美華國際醫療科技有限公司（"MHUA"或"公司"）(納斯達克股票代碼：MHUA) 是一家享有聲譽的一、二、三類一次性醫療設備製造商和提供商，在中國設有運營子公司。今日宣佈，於2024年10月3日，該公司收到了納斯達克股票市場有限責任公司（"納斯達克"）上市資格部的一封通知信（"通知信"），通知公司已恢復符合納斯達克上市規則5450(a)(1)中規定的最低買盤價格要求（"最低買盤價格要求"）。
As previously reported, the Company was notified on April 2, 2024, that its ordinary shares failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the Nasdaq Minimum Bid Price Requirement.
正如之前報告的那樣，公司於2024年4月2日收到通知，其普通股未能在前30個連續工作日內維持每股$1.00的最低買盤價格，這是納斯達克最低買盤價格要求的要求。
譯文內容由第三人軟體翻譯。
